Our Team

Orlance, inc

Kris Alto

CEO

25 years of bioengineering, innovation development, regulatory and clinical affairs, product launch, VC and executive experience.

Deb Fuller

PhD, CTO

co-inventor of MACH-1 technology, formerly at PowderJect, UW Professor, the lab focuses on NA vaccines for multiple pathogens.

Jim Mullins

PhD

co-founder and SAB member, UW, molecular and computational approaches vaccine design, the originator of conserved element (CE) approach to vaccine development.

Ken Bagley

PhD, Dir. R&D

15 years in NA vaccine field, developed genetic adjuvant platform at Profectus Biosciences, Inc.

Hannah Frizzell

PhD

Bioengineer, Immunology, and nano delivery system experience.